Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Pacira BioSciences, Inc. (PCRX) had Free Cash Flow per Share of $2.10 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$179.52M |
|
$5.43M |
|
$34.28M |
|
$145.24M |
|
$173.15M |
|
$6.36M |
|
$3.16M |
|
$9.52M |
|
$9.52M |
|
$5.43M |
|
$5.43M |
|
$5.43M |
|
$5.43M |
|
$6.36M |
|
$28.23M |
|
44.04M |
|
44.46M |
|
$0.12 |
|
$0.12 |
|
| Balance Sheet Financials | |
$562.75M |
|
$147.39M |
|
$734.83M |
|
$1.30B |
|
$107.08M |
|
$376.72M |
|
$463.29M |
|
$570.36M |
|
$727.21M |
|
$324.50M |
|
$727.21M |
|
42.97M |
|
| Cash Flow Statement Financials | |
$108.31M |
|
$80.15M |
|
$-317.98M |
|
$276.77M |
|
$147.59M |
|
$-129.19M |
|
$44.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.26 |
|
-- |
|
-- |
|
0.34 |
|
0.52 |
|
80.91% |
|
3.54% |
|
3.54% |
|
-- |
|
5.31% |
|
3.03% |
|
$93.19M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.22 |
|
1.56 |
|
57.79 |
|
0.75% |
|
1.67% |
|
0.42% |
|
0.49% |
|
$16.93 |
|
|
Free Cash Flow per Share |
$2.10 |
$2.44 |
|